Treatment of chronic graft-versus-host disease with combination extracorporeal photopheresis and the ROCK2 inhibitor belumosudil can reverse sclerodermatous changes

被引：0
|
作者：
Swallow, M. [1 ]
Chang, J. [1 ]
Carlson, K. [1 ]
Odell, I. D. [1 ]
Girardi, M. [1 ]
机构：
[1] Yale Sch Med, New Haven, CT USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2024年 / 144卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
LB931
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [31] Belumosudil Rho-associated coiled coil-containing protein kinase 2 (ROCK2) inhibitor Treatment of chronic graft-versus-host disease Treatment of systemic sclerosis
    Ussowicz, M.
    DRUGS OF THE FUTURE, 2021, 46 (05) : 349 - 357
  • [32] Efficacy and infectious complications during extracorporeal photopheresis treatment of chronic graft-versus-host disease
    Bykova, T. A.
    Kozlov, A. V.
    Estrina, M. A.
    Stancheva, N. V.
    Semenova, E. V.
    Zubarovskaya, L. S.
    Afanasyev, B. A.
    Gorbacheva, R. M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S407 - S407
  • [33] Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease
    Franklin, Cindy
    Cesko, Elvir
    Hillen, Uwe
    Schilling, Bastian
    Brandau, Sven
    PLOS ONE, 2015, 10 (08):
  • [34] Extracorporeal photopheresis for acute and chronic graft-versus-host disease: Does it work?
    Couriel, D
    Hosing, C
    Saliba, R
    Shpall, EJ
    Andelini, P
    Popat, U
    Donato, M
    Champlin, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (01) : 37 - 40
  • [35] Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease
    Gavriilaki, Eleni
    Papchianou, Eleni
    Karavalakis, Giorgos
    Batsis, Ioannis
    Panteliadou, Alkistis
    Lazaridou, Andriana
    Mallouri, Despina
    Constantinou, Varnavas
    Karvouni, Paraskevi
    Evangelidis, Paschalis
    Papakonstantinou, Anna
    Papalexandri, Apostolia
    Kaloyannidis, Panayotis
    Spyridis, Nikolaos
    Bousiou, Zoi
    Vardi, Anna
    Yannaki, Evangelia
    Sotiropoulos, Damianos
    Sakellari, Ioanna
    PHARMACEUTICALS, 2024, 17 (10)
  • [36] Extracorporeal photopheresis (ECP) in extensive chronic graft-versus-host disease (GVHD).
    Rabitsch, W
    Reiter, E
    Keil, F
    Malzer, R
    VolcPlatzer, B
    Kalhs, P
    Gmeinhart, B
    Guevara, C
    Knobler, R
    Greinix, HT
    BLOOD, 1997, 90 (10) : 1676 - 1676
  • [37] Imatinib mesylate in the treatment of sclerodermatous chronic graft-versus-host disease
    Yakoub-Agha, I.
    Magro, L.
    Catteau, B.
    Coiteux, V.
    Terriou, L.
    Jouet, J. P.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S190 - S190
  • [38] Extracorporeal photopheresis for the treatment of steroid-refractory and -intolerant chronic graft-versus-host disease
    Pawarode, A.
    Hahn, T.
    Battiwalla, M.
    Paplham, P.
    Smiley, S. L.
    McCarthy, P. L., Jr.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S235 - S235
  • [39] A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease
    Rafei, Hind
    Kharfan-Dabaja, Mohamed A.
    Nishihori, Taiga
    BIOMEDICINES, 2017, 5 (04)
  • [40] EXTRACORPOREAL PHOTOPHERESIS IN THE TREATMENT OF CHRONIC GRAFT-VERSUS-HOST- DISEASE
    Vasilyeva, V. A.
    Kuzmina, L. A.
    Drokov, M. Yu
    Dovydenko, M., V
    Koroleva, O. M.
    Dubnyak, D. S.
    Dmitrova, A. A.
    Nikiforova, N. M.
    Starikova, O. S.
    Komelskikh, D., V
    Sherbakova, A. A.
    Gaponova, T., V
    Parovichnikova, E. N.
    Savchenko, V. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (02): : 202 - 215
12345